AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies
2018 · Cancer Discovery · 409 citations
https://doi.org/10.1158/2159-8290.cd-18-0387
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
1.3K
Citations
17
h-index
21
i10-index
Liusheng Zhu is an academic researcher from Sunesis (United States). The author has contributed to research in topics: Organoselenium and organotellurium chemistry & Sulfur-Based Synthesis Techniques & Diabetes Treatment and Management. The author has an h-index of 17, co-authored 30 publications.
https://doi.org/10.1158/2159-8290.cd-18-0387
https://doi.org/10.1097/cej.0000000000000922
Click to start Chat